当前位置:首页 - 行情中心 - 奇正藏药(002287) - 财务分析 - 现金流量表

奇正藏药

(002287)

  

流通市值:154.90亿  总市值:155.21亿
流通股本:5.70亿   总股本:5.71亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,456,518,970.89727,120,533.532,245,453,250.871,480,860,322.67
  收到的税费返还--31,649,916.8331,659,549.15
  收到其他与经营活动有关的现金83,716,789.6252,098,724.2383,619,609.0771,839,629.89
  经营活动现金流入小计1,540,235,760.51779,219,257.762,360,722,776.771,584,359,501.71
  购买商品、接受劳务支付的现金119,895,722.4755,828,771.01161,577,820.5492,107,249.71
  支付给职工以及为职工支付的现金325,736,244.01196,303,706.65532,909,660.22426,538,029.52
  支付的各项税费168,833,845.8480,275,601.43364,994,444.8267,247,054.09
  支付其他与经营活动有关的现金434,528,947.96190,992,629.72844,489,558.29567,250,482.89
  经营活动现金流出小计1,048,994,760.28523,400,708.811,903,971,483.851,353,142,816.21
  经营活动产生的现金流量净额491,241,000.23255,818,548.95456,751,292.92231,216,685.5
二、投资活动产生的现金流量:
  收回投资收到的现金897,356,712.69630,636,091.782,172,924,242.061,469,981,773.58
  取得投资收益收到的现金37,282,372.9718,954,392.671,205,335.5635,394,771.7
  投资活动现金流入小计934,639,085.66649,590,484.382,244,129,577.621,505,376,545.28
  购建固定资产、无形资产和其他长期资产支付的现金65,592,760.7347,996,662.45255,443,057.03203,308,377.86
  投资支付的现金1,002,430,000500,000,0002,506,703,904.111,625,703,904.11
  投资活动现金流出小计1,068,022,760.73547,996,662.452,762,146,961.141,829,012,281.97
  投资活动产生的现金流量净额-133,383,675.07101,593,821.93-518,017,383.52-323,635,736.69
三、筹资活动产生的现金流量:
  取得借款收到的现金645,627,349.5551,527,349.5811,872,650.5753,500,000
  收到其他与筹资活动有关的现金500,000500,000--
  筹资活动现金流入小计646,127,349.5552,027,349.5811,872,650.5753,500,000
  偿还债务支付的现金706,700,000453,935,000660,487,821.43452,700,000
  分配股利、利润或偿付利息支付的现金121,173,143.35118,543,220.13282,448,745.74279,584,500.16
  支付其他与筹资活动有关的现金61,310,078.613,408,499.077,143,987.571,021,952.65
  筹资活动现金流出小计889,183,221.96575,886,719.2950,080,554.74733,306,452.81
  筹资活动产生的现金流量净额-243,055,872.46-23,859,369.7-138,207,904.2420,193,547.19
四、汇率变动对现金及现金等价物的影响-160,905.25-54,508.06561,713.43-402,847.11
五、现金及现金等价物净增加额114,640,547.45333,498,493.12-198,912,281.41-72,628,351.11
  加:期初现金及现金等价物余额189,591,493.5189,591,493.5388,503,774.91388,503,774.91
  期末现金及现金等价物余额304,232,040.95523,089,986.62189,591,493.5315,875,423.8
补充资料:
  净利润359,452,574.29-581,369,645.72-
  资产减值准备-766,877.8-1,179,197.47-
  固定资产和投资性房地产折旧56,579,777.24-101,271,583.97-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧56,579,777.24-101,271,583.97-
  无形资产摊销13,510,573.81-26,960,037.32-
  长期待摊费用摊销428,256.04-1,028,041.55-
  处置固定资产、无形资产和其他长期资产的损失-909,309.6---
  固定资产报废损失30,457.08-580,487.28-
  公允价值变动损失-43,330,873.55--105,137,133.35-
  财务费用29,416,854.52-57,787,374.57-
  投资损失3,930,453.82-4,821,968.32-
  递延所得税498,804.63-8,705,415.72-
  其中:递延所得税资产减少3,887,068.58-3,364,282.44-
    递延所得税负债增加-3,388,263.95-5,341,133.28-
  存货的减少-19,296,137.42--29,723,994.82-
  经营性应收项目的减少227,208,260.9--278,789,064.9-
  经营性应付项目的增加-138,907,898.69-75,669,367.72-
  现金的期末余额304,232,040.95-189,591,493.5-
  减:现金的期初余额189,591,493.5-388,503,774.91-
  现金及现金等价物的净增加额114,640,547.45--198,912,281.41-
公告日期2025-08-232025-04-252025-04-252024-10-30
审计意见(境内)标准无保留意见
TOP↑